Sign In
Buy BICX
$0.378
+0 (+0%)
At Close: Jun 03, 2026
Head-To-Head Analysis: Biocorrx (OTCMKTS:BICX) and IceCure Medical (NASDAQ:ICCM)
02:36am, Friday, 27'th Mar 2026
IceCure Medical (NASDAQ: ICCM - Get Free Report) and Biocorrx (OTCMKTS:BICX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two compan
GoodRx (NASDAQ:GDRX) versus Biocorrx (OTCMKTS:BICX) Critical Comparison
01:46am, Monday, 23'rd Mar 2026
Biocorrx (OTCMKTS:BICX - Get Free Report) and GoodRx (NASDAQ: GDRX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based
Biocorrx (OTCMKTS:BICX) Stock Price Crosses Above 50 Day Moving Average – Here’s What Happened
03:57am, Thursday, 12'th Mar 2026
Biocorrx Inc. (OTCMKTS:BICX - Get Free Report)'s share price crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.32 and traded as high as $
Powell Max Limited Successfully Repositions for Its Next Phase of Growth
08:30am, Monday, 09'th Mar 2026
Hong Kong, TX, March 09, 2026 (GLOBE NEWSWIRE) -- Powell Max Limited (Nasdaq: PMAX) ("Powell Max" or the "Company"), a financial communications services provider, is pleased to provide the following c
Biocorrx (OTCMKTS:BICX) Stock Price Crosses Below Fifty Day Moving Average – Should You Sell?
05:07am, Tuesday, 23'rd Dec 2025
Biocorrx Inc. (OTCMKTS:BICX - Get Free Report)'s share price crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $0.38 and traded as low as $0.27
BioCorRx Inc. to Present at the Life Sciences Virtual Investor Forum December 11th
08:35am, Wednesday, 10'th Dec 2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as
Biocorrx (OTCMKTS:BICX) vs. CVS Health (NYSE:CVS) Critical Survey
02:10am, Sunday, 30'th Nov 2025
Biocorrx (OTCMKTS:BICX - Get Free Report) and CVS Health (NYSE: CVS - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the str
Diamond Equity Research Releases Update Note on BioCorRx®, Inc. (OTCQB: BICX)
08:00am, Wednesday, 19'th Nov 2025
New York, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update report on BioCorRx®, Inc. (OT
Diamond Equity Research Initiates Coverage on BioCorRx®, Inc. (OTCQB: BICX)
08:00am, Monday, 25'th Aug 2025
New York, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has initiated coverage of BioCorRx®, Inc. (OTCQB: BI
BioCorRx Reports Business Update for the Second Quarter of 2024
08:30am, Thursday, 15'th Aug 2024
ANAHEIM, CA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, tod
BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia
08:30am, Wednesday, 03'rd Apr 2024
ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer of innovative treatment programs for substance use and related disord
BioCorRx Reports Business Update for 2023
08:30am, Tuesday, 02'nd Apr 2024
ANAHEIM, CA, April 02, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and
ANAHEIM, CA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance use and r
BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
09:52am, Thursday, 08'th Feb 2024
ANAHEIM, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and r
BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
08:30am, Tuesday, 09'th Jan 2024
ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and r
